Clinical Trial Update: Study of Bevacizumab Followed by Bevacizumab Consolidation for Ovarian Cancer [Phase 2]

View source ↗

Summary

Phase II trial evaluating bevacizumab followed by consolidation therapy for advanced ovarian cancer and related tumors; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer
• Ovarian Carcinosarcoma
• Peritoneal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: University of Oklahoma | Conditions: Advanced Ovarian Carcinoma, Primary Peritoneal Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2017-07-02